ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,391, issued on Sept. 8, was assigned to BASF SE (Ludwigshafen am Rhein, Germany).
"Bacillus cell with reduced lipase and/or esterase side activities" was invented by Stefan Jenewein (Ludwigshafen, Germany), Max Fabian Felle (Ludwigshafen, Germany), Christopher Sauer (Ludwigshafen, Germany) and Paul Igor Costea (Ludwigshafen, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a modified Bacillus cell for the production of a compound of interest, wherein the Bacillus cell comprises a genetic modification that leads to decreased production of enzymes with lipase and/or esterase activity. The use of compounds of intere...